Global Left Ventricular Assist Device Market

Left Ventricular Assist Device Comprehensive Study by Type (Transcutaneous Ventricular Assist Device, Implantable Ventricular Assist Device), Application (Bridge-to-Transplant Therapy, Destination Therapy, Bridge-to-Recovery Therapy, Bridge-to-Candidacy Therapy), Flow (Pulsatile Flow, Continuous Flow) Players and Region - Global Market Outlook to 2030

Left Ventricular Assist Device Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Left Ventricular Assist Device
A left ventricular assist device is a pump that used for patients who have reached end-stage heart failure. It also known as a mechanical circulatory support device. It is an implantable mechanical pump that helps pump blood from the lower chambers of heart to the rest of body. It is implanted inside a person’s chest to help a weakened heart pump blood. It doesn’t replace the heart but it just helps it do its job.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Left Ventricular Assist Device market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abiomed, Inc. (United States), Asahi Kasei Corporation (Japan), Abbott Laboratories (United States), Berlin Heart GmbH (Germany), Calon Cardio-Technology Ltd. (United Kingdom), CardiacAssist Technologies (United States), Jarvik Heart, Inc. (United States), Medtronic plc. (Ireland), ReliantHeart, Inc. (United States) and Terumo Medical Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Thoratec Corporation (United States) and Evaheart, Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Left Ventricular Assist Device market by Type (Transcutaneous Ventricular Assist Device and Implantable Ventricular Assist Device), Application (Bridge-to-Transplant Therapy, Destination Therapy, Bridge-to-Recovery Therapy and Bridge-to-Candidacy Therapy) and Region.



On the basis of geography, the market of Left Ventricular Assist Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Flow, the sub-segment i.e. Pulsatile Flow will boost the Left Ventricular Assist Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Continuous Adoption in Ventricular Assist Device

Market Growth Drivers:
High Cardiovascular Disease Prevalence Leading To High Heart Failure Rates and Rise in the Awareness among the People

Challenges:
High Cost of Ventricular Assist Device Implantation

Restraints:
Risk of Internal Bleeding and Infections

Opportunities:
Increasing Number of New Product Approval and Growing Geriatric Population

In June 2023, In the first step towards securing FDA approval, Israel-based device maker Magenta Medical is commencing an early feasibility study with its Elevate percutaneous Left Ventricular Assist Device (pLVAD) for high-risk percutaneous coronary intervention (HR-PCI). Being the world’s smallest heart pump, it provides temporary mechanical circulatory support during HR-PCI procedures.


Key Target Audience
Left Ventricular Assist Device Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Transcutaneous Ventricular Assist Device
  • Implantable Ventricular Assist Device
By Application
  • Bridge-to-Transplant Therapy
  • Destination Therapy
  • Bridge-to-Recovery Therapy
  • Bridge-to-Candidacy Therapy
By Flow
  • Pulsatile Flow
  • Continuous Flow

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Cardiovascular Disease Prevalence Leading To High Heart Failure Rates
      • 3.2.2. Rise in the Awareness among the People
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Ventricular Assist Device Implantation
    • 3.4. Market Trends
      • 3.4.1. Continuous Adoption in Ventricular Assist Device
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Left Ventricular Assist Device, by Type, Application, Flow and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Left Ventricular Assist Device (Value)
      • 5.2.1. Global Left Ventricular Assist Device by: Type (Value)
        • 5.2.1.1. Transcutaneous Ventricular Assist Device
        • 5.2.1.2. Implantable Ventricular Assist Device
      • 5.2.2. Global Left Ventricular Assist Device by: Application (Value)
        • 5.2.2.1. Bridge-to-Transplant Therapy
        • 5.2.2.2. Destination Therapy
        • 5.2.2.3. Bridge-to-Recovery Therapy
        • 5.2.2.4. Bridge-to-Candidacy Therapy
      • 5.2.3. Global Left Ventricular Assist Device by: Flow (Value)
        • 5.2.3.1. Pulsatile Flow
        • 5.2.3.2. Continuous Flow
      • 5.2.4. Global Left Ventricular Assist Device Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Left Ventricular Assist Device (Volume)
      • 5.3.1. Global Left Ventricular Assist Device by: Type (Volume)
        • 5.3.1.1. Transcutaneous Ventricular Assist Device
        • 5.3.1.2. Implantable Ventricular Assist Device
      • 5.3.2. Global Left Ventricular Assist Device by: Application (Volume)
        • 5.3.2.1. Bridge-to-Transplant Therapy
        • 5.3.2.2. Destination Therapy
        • 5.3.2.3. Bridge-to-Recovery Therapy
        • 5.3.2.4. Bridge-to-Candidacy Therapy
      • 5.3.3. Global Left Ventricular Assist Device by: Flow (Volume)
        • 5.3.3.1. Pulsatile Flow
        • 5.3.3.2. Continuous Flow
      • 5.3.4. Global Left Ventricular Assist Device Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Left Ventricular Assist Device (Price)
      • 5.4.1. Global Left Ventricular Assist Device by: Type (Price)
  • 6. Left Ventricular Assist Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abiomed, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Asahi Kasei Corporation (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Berlin Heart GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Calon Cardio-Technology Ltd. (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. CardiacAssist Technologies (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Jarvik Heart, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medtronic plc. (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. ReliantHeart, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Terumo Medical Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Left Ventricular Assist Device Sale, by Type, Application, Flow and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Left Ventricular Assist Device (Value)
      • 7.2.1. Global Left Ventricular Assist Device by: Type (Value)
        • 7.2.1.1. Transcutaneous Ventricular Assist Device
        • 7.2.1.2. Implantable Ventricular Assist Device
      • 7.2.2. Global Left Ventricular Assist Device by: Application (Value)
        • 7.2.2.1. Bridge-to-Transplant Therapy
        • 7.2.2.2. Destination Therapy
        • 7.2.2.3. Bridge-to-Recovery Therapy
        • 7.2.2.4. Bridge-to-Candidacy Therapy
      • 7.2.3. Global Left Ventricular Assist Device by: Flow (Value)
        • 7.2.3.1. Pulsatile Flow
        • 7.2.3.2. Continuous Flow
      • 7.2.4. Global Left Ventricular Assist Device Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Left Ventricular Assist Device (Volume)
      • 7.3.1. Global Left Ventricular Assist Device by: Type (Volume)
        • 7.3.1.1. Transcutaneous Ventricular Assist Device
        • 7.3.1.2. Implantable Ventricular Assist Device
      • 7.3.2. Global Left Ventricular Assist Device by: Application (Volume)
        • 7.3.2.1. Bridge-to-Transplant Therapy
        • 7.3.2.2. Destination Therapy
        • 7.3.2.3. Bridge-to-Recovery Therapy
        • 7.3.2.4. Bridge-to-Candidacy Therapy
      • 7.3.3. Global Left Ventricular Assist Device by: Flow (Volume)
        • 7.3.3.1. Pulsatile Flow
        • 7.3.3.2. Continuous Flow
      • 7.3.4. Global Left Ventricular Assist Device Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Left Ventricular Assist Device (Price)
      • 7.4.1. Global Left Ventricular Assist Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Left Ventricular Assist Device: by Type(USD Million)
  • Table 2. Left Ventricular Assist Device Transcutaneous Ventricular Assist Device , by Region USD Million (2018-2023)
  • Table 3. Left Ventricular Assist Device Implantable Ventricular Assist Device , by Region USD Million (2018-2023)
  • Table 4. Left Ventricular Assist Device: by Application(USD Million)
  • Table 5. Left Ventricular Assist Device Bridge-to-Transplant Therapy , by Region USD Million (2018-2023)
  • Table 6. Left Ventricular Assist Device Destination Therapy , by Region USD Million (2018-2023)
  • Table 7. Left Ventricular Assist Device Bridge-to-Recovery Therapy , by Region USD Million (2018-2023)
  • Table 8. Left Ventricular Assist Device Bridge-to-Candidacy Therapy , by Region USD Million (2018-2023)
  • Table 9. Left Ventricular Assist Device: by Flow(USD Million)
  • Table 10. Left Ventricular Assist Device Pulsatile Flow , by Region USD Million (2018-2023)
  • Table 11. Left Ventricular Assist Device Continuous Flow , by Region USD Million (2018-2023)
  • Table 12. South America Left Ventricular Assist Device, by Country USD Million (2018-2023)
  • Table 13. South America Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 14. South America Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 15. South America Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 16. Brazil Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 17. Brazil Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 18. Brazil Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 19. Argentina Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 20. Argentina Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 21. Argentina Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 22. Rest of South America Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 23. Rest of South America Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 24. Rest of South America Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 25. Asia Pacific Left Ventricular Assist Device, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 28. Asia Pacific Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 29. China Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 30. China Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 31. China Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 32. Japan Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 33. Japan Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 34. Japan Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 35. India Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 36. India Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 37. India Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 38. South Korea Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 39. South Korea Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 40. South Korea Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 41. Taiwan Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 42. Taiwan Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 43. Taiwan Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 44. Australia Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 45. Australia Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 46. Australia Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 50. Europe Left Ventricular Assist Device, by Country USD Million (2018-2023)
  • Table 51. Europe Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 52. Europe Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 53. Europe Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 54. Germany Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 55. Germany Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 56. Germany Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 57. France Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 58. France Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 59. France Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 60. Italy Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 61. Italy Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 62. Italy Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 63. United Kingdom Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 64. United Kingdom Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 65. United Kingdom Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 66. Netherlands Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 67. Netherlands Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 68. Netherlands Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 69. Rest of Europe Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 70. Rest of Europe Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 71. Rest of Europe Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 72. MEA Left Ventricular Assist Device, by Country USD Million (2018-2023)
  • Table 73. MEA Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 74. MEA Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 75. MEA Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 76. Middle East Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 77. Middle East Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 78. Middle East Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 79. Africa Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 80. Africa Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 81. Africa Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 82. North America Left Ventricular Assist Device, by Country USD Million (2018-2023)
  • Table 83. North America Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 84. North America Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 85. North America Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 86. United States Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 87. United States Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 88. United States Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 89. Canada Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 90. Canada Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 91. Canada Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 92. Mexico Left Ventricular Assist Device, by Type USD Million (2018-2023)
  • Table 93. Mexico Left Ventricular Assist Device, by Application USD Million (2018-2023)
  • Table 94. Mexico Left Ventricular Assist Device, by Flow USD Million (2018-2023)
  • Table 95. Left Ventricular Assist Device Sales: by Type(K Units)
  • Table 96. Left Ventricular Assist Device Sales Transcutaneous Ventricular Assist Device , by Region K Units (2018-2023)
  • Table 97. Left Ventricular Assist Device Sales Implantable Ventricular Assist Device , by Region K Units (2018-2023)
  • Table 98. Left Ventricular Assist Device Sales: by Application(K Units)
  • Table 99. Left Ventricular Assist Device Sales Bridge-to-Transplant Therapy , by Region K Units (2018-2023)
  • Table 100. Left Ventricular Assist Device Sales Destination Therapy , by Region K Units (2018-2023)
  • Table 101. Left Ventricular Assist Device Sales Bridge-to-Recovery Therapy , by Region K Units (2018-2023)
  • Table 102. Left Ventricular Assist Device Sales Bridge-to-Candidacy Therapy , by Region K Units (2018-2023)
  • Table 103. Left Ventricular Assist Device Sales: by Flow(K Units)
  • Table 104. Left Ventricular Assist Device Sales Pulsatile Flow , by Region K Units (2018-2023)
  • Table 105. Left Ventricular Assist Device Sales Continuous Flow , by Region K Units (2018-2023)
  • Table 106. South America Left Ventricular Assist Device Sales, by Country K Units (2018-2023)
  • Table 107. South America Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 108. South America Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 109. South America Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 110. Brazil Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 111. Brazil Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 112. Brazil Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 113. Argentina Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 114. Argentina Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 115. Argentina Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 116. Rest of South America Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 117. Rest of South America Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 118. Rest of South America Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 119. Asia Pacific Left Ventricular Assist Device Sales, by Country K Units (2018-2023)
  • Table 120. Asia Pacific Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 121. Asia Pacific Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 122. Asia Pacific Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 123. China Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 124. China Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 125. China Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 126. Japan Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 127. Japan Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 128. Japan Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 129. India Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 130. India Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 131. India Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 132. South Korea Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 133. South Korea Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 134. South Korea Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 135. Taiwan Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 136. Taiwan Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 137. Taiwan Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 138. Australia Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 139. Australia Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 140. Australia Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 141. Rest of Asia-Pacific Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 142. Rest of Asia-Pacific Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 143. Rest of Asia-Pacific Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 144. Europe Left Ventricular Assist Device Sales, by Country K Units (2018-2023)
  • Table 145. Europe Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 146. Europe Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 147. Europe Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 148. Germany Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 149. Germany Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 150. Germany Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 151. France Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 152. France Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 153. France Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 154. Italy Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 155. Italy Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 156. Italy Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 157. United Kingdom Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 158. United Kingdom Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 159. United Kingdom Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 160. Netherlands Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 161. Netherlands Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 162. Netherlands Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 163. Rest of Europe Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 164. Rest of Europe Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 165. Rest of Europe Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 166. MEA Left Ventricular Assist Device Sales, by Country K Units (2018-2023)
  • Table 167. MEA Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 168. MEA Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 169. MEA Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 170. Middle East Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 171. Middle East Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 172. Middle East Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 173. Africa Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 174. Africa Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 175. Africa Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 176. North America Left Ventricular Assist Device Sales, by Country K Units (2018-2023)
  • Table 177. North America Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 178. North America Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 179. North America Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 180. United States Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 181. United States Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 182. United States Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 183. Canada Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 184. Canada Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 185. Canada Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 186. Mexico Left Ventricular Assist Device Sales, by Type K Units (2018-2023)
  • Table 187. Mexico Left Ventricular Assist Device Sales, by Application K Units (2018-2023)
  • Table 188. Mexico Left Ventricular Assist Device Sales, by Flow K Units (2018-2023)
  • Table 189. Left Ventricular Assist Device: by Type(USD/Units)
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Left Ventricular Assist Device: by Type(USD Million)
  • Table 201. Left Ventricular Assist Device Transcutaneous Ventricular Assist Device , by Region USD Million (2025-2030)
  • Table 202. Left Ventricular Assist Device Implantable Ventricular Assist Device , by Region USD Million (2025-2030)
  • Table 203. Left Ventricular Assist Device: by Application(USD Million)
  • Table 204. Left Ventricular Assist Device Bridge-to-Transplant Therapy , by Region USD Million (2025-2030)
  • Table 205. Left Ventricular Assist Device Destination Therapy , by Region USD Million (2025-2030)
  • Table 206. Left Ventricular Assist Device Bridge-to-Recovery Therapy , by Region USD Million (2025-2030)
  • Table 207. Left Ventricular Assist Device Bridge-to-Candidacy Therapy , by Region USD Million (2025-2030)
  • Table 208. Left Ventricular Assist Device: by Flow(USD Million)
  • Table 209. Left Ventricular Assist Device Pulsatile Flow , by Region USD Million (2025-2030)
  • Table 210. Left Ventricular Assist Device Continuous Flow , by Region USD Million (2025-2030)
  • Table 211. South America Left Ventricular Assist Device, by Country USD Million (2025-2030)
  • Table 212. South America Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 213. South America Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 214. South America Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 215. Brazil Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 216. Brazil Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 217. Brazil Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 218. Argentina Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 219. Argentina Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 220. Argentina Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 221. Rest of South America Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 222. Rest of South America Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 223. Rest of South America Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 224. Asia Pacific Left Ventricular Assist Device, by Country USD Million (2025-2030)
  • Table 225. Asia Pacific Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 226. Asia Pacific Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 227. Asia Pacific Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 228. China Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 229. China Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 230. China Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 231. Japan Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 232. Japan Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 233. Japan Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 234. India Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 235. India Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 236. India Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 237. South Korea Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 238. South Korea Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 239. South Korea Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 240. Taiwan Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 241. Taiwan Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 242. Taiwan Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 243. Australia Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 244. Australia Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 245. Australia Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 246. Rest of Asia-Pacific Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 247. Rest of Asia-Pacific Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 248. Rest of Asia-Pacific Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 249. Europe Left Ventricular Assist Device, by Country USD Million (2025-2030)
  • Table 250. Europe Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 251. Europe Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 252. Europe Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 253. Germany Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 254. Germany Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 255. Germany Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 256. France Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 257. France Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 258. France Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 259. Italy Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 260. Italy Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 261. Italy Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 262. United Kingdom Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 263. United Kingdom Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 264. United Kingdom Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 265. Netherlands Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 266. Netherlands Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 267. Netherlands Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 268. Rest of Europe Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 269. Rest of Europe Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 270. Rest of Europe Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 271. MEA Left Ventricular Assist Device, by Country USD Million (2025-2030)
  • Table 272. MEA Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 273. MEA Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 274. MEA Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 275. Middle East Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 276. Middle East Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 277. Middle East Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 278. Africa Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 279. Africa Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 280. Africa Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 281. North America Left Ventricular Assist Device, by Country USD Million (2025-2030)
  • Table 282. North America Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 283. North America Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 284. North America Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 285. United States Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 286. United States Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 287. United States Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 288. Canada Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 289. Canada Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 290. Canada Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 291. Mexico Left Ventricular Assist Device, by Type USD Million (2025-2030)
  • Table 292. Mexico Left Ventricular Assist Device, by Application USD Million (2025-2030)
  • Table 293. Mexico Left Ventricular Assist Device, by Flow USD Million (2025-2030)
  • Table 294. Left Ventricular Assist Device Sales: by Type(K Units)
  • Table 295. Left Ventricular Assist Device Sales Transcutaneous Ventricular Assist Device , by Region K Units (2025-2030)
  • Table 296. Left Ventricular Assist Device Sales Implantable Ventricular Assist Device , by Region K Units (2025-2030)
  • Table 297. Left Ventricular Assist Device Sales: by Application(K Units)
  • Table 298. Left Ventricular Assist Device Sales Bridge-to-Transplant Therapy , by Region K Units (2025-2030)
  • Table 299. Left Ventricular Assist Device Sales Destination Therapy , by Region K Units (2025-2030)
  • Table 300. Left Ventricular Assist Device Sales Bridge-to-Recovery Therapy , by Region K Units (2025-2030)
  • Table 301. Left Ventricular Assist Device Sales Bridge-to-Candidacy Therapy , by Region K Units (2025-2030)
  • Table 302. Left Ventricular Assist Device Sales: by Flow(K Units)
  • Table 303. Left Ventricular Assist Device Sales Pulsatile Flow , by Region K Units (2025-2030)
  • Table 304. Left Ventricular Assist Device Sales Continuous Flow , by Region K Units (2025-2030)
  • Table 305. South America Left Ventricular Assist Device Sales, by Country K Units (2025-2030)
  • Table 306. South America Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 307. South America Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 308. South America Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 309. Brazil Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 310. Brazil Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 311. Brazil Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 312. Argentina Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 313. Argentina Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 314. Argentina Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 315. Rest of South America Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 316. Rest of South America Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 317. Rest of South America Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 318. Asia Pacific Left Ventricular Assist Device Sales, by Country K Units (2025-2030)
  • Table 319. Asia Pacific Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 320. Asia Pacific Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 321. Asia Pacific Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 322. China Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 323. China Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 324. China Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 325. Japan Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 326. Japan Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 327. Japan Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 328. India Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 329. India Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 330. India Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 331. South Korea Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 332. South Korea Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 333. South Korea Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 334. Taiwan Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 335. Taiwan Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 336. Taiwan Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 337. Australia Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 338. Australia Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 339. Australia Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 340. Rest of Asia-Pacific Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 341. Rest of Asia-Pacific Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 342. Rest of Asia-Pacific Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 343. Europe Left Ventricular Assist Device Sales, by Country K Units (2025-2030)
  • Table 344. Europe Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 345. Europe Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 346. Europe Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 347. Germany Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 348. Germany Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 349. Germany Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 350. France Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 351. France Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 352. France Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 353. Italy Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 354. Italy Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 355. Italy Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 356. United Kingdom Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 357. United Kingdom Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 358. United Kingdom Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 359. Netherlands Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 360. Netherlands Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 361. Netherlands Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 362. Rest of Europe Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 363. Rest of Europe Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 364. Rest of Europe Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 365. MEA Left Ventricular Assist Device Sales, by Country K Units (2025-2030)
  • Table 366. MEA Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 367. MEA Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 368. MEA Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 369. Middle East Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 370. Middle East Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 371. Middle East Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 372. Africa Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 373. Africa Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 374. Africa Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 375. North America Left Ventricular Assist Device Sales, by Country K Units (2025-2030)
  • Table 376. North America Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 377. North America Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 378. North America Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 379. United States Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 380. United States Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 381. United States Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 382. Canada Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 383. Canada Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 384. Canada Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 385. Mexico Left Ventricular Assist Device Sales, by Type K Units (2025-2030)
  • Table 386. Mexico Left Ventricular Assist Device Sales, by Application K Units (2025-2030)
  • Table 387. Mexico Left Ventricular Assist Device Sales, by Flow K Units (2025-2030)
  • Table 388. Left Ventricular Assist Device: by Type(USD/Units)
  • Table 389. Research Programs/Design for This Report
  • Table 390. Key Data Information from Secondary Sources
  • Table 391. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Left Ventricular Assist Device: by Type USD Million (2018-2023)
  • Figure 5. Global Left Ventricular Assist Device: by Application USD Million (2018-2023)
  • Figure 6. Global Left Ventricular Assist Device: by Flow USD Million (2018-2023)
  • Figure 7. South America Left Ventricular Assist Device Share (%), by Country
  • Figure 8. Asia Pacific Left Ventricular Assist Device Share (%), by Country
  • Figure 9. Europe Left Ventricular Assist Device Share (%), by Country
  • Figure 10. MEA Left Ventricular Assist Device Share (%), by Country
  • Figure 11. North America Left Ventricular Assist Device Share (%), by Country
  • Figure 12. Global Left Ventricular Assist Device: by Type K Units (2018-2023)
  • Figure 13. Global Left Ventricular Assist Device: by Application K Units (2018-2023)
  • Figure 14. Global Left Ventricular Assist Device: by Flow K Units (2018-2023)
  • Figure 15. South America Left Ventricular Assist Device Share (%), by Country
  • Figure 16. Asia Pacific Left Ventricular Assist Device Share (%), by Country
  • Figure 17. Europe Left Ventricular Assist Device Share (%), by Country
  • Figure 18. MEA Left Ventricular Assist Device Share (%), by Country
  • Figure 19. North America Left Ventricular Assist Device Share (%), by Country
  • Figure 20. Global Left Ventricular Assist Device: by Type USD/Units (2018-2023)
  • Figure 21. Global Left Ventricular Assist Device share by Players 2023 (%)
  • Figure 22. Global Left Ventricular Assist Device share by Players (Top 3) 2023(%)
  • Figure 23. Global Left Ventricular Assist Device share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Abiomed, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abiomed, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Asahi Kasei Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 28. Asahi Kasei Corporation (Japan) Revenue: by Geography 2023
  • Figure 29. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 31. Berlin Heart GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Berlin Heart GmbH (Germany) Revenue: by Geography 2023
  • Figure 33. Calon Cardio-Technology Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Calon Cardio-Technology Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 35. CardiacAssist Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 36. CardiacAssist Technologies (United States) Revenue: by Geography 2023
  • Figure 37. Jarvik Heart, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Jarvik Heart, Inc. (United States) Revenue: by Geography 2023
  • Figure 39. Medtronic plc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 40. Medtronic plc. (Ireland) Revenue: by Geography 2023
  • Figure 41. ReliantHeart, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. ReliantHeart, Inc. (United States) Revenue: by Geography 2023
  • Figure 43. Terumo Medical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 44. Terumo Medical Corporation (United States) Revenue: by Geography 2023
  • Figure 45. Global Left Ventricular Assist Device: by Type USD Million (2025-2030)
  • Figure 46. Global Left Ventricular Assist Device: by Application USD Million (2025-2030)
  • Figure 47. Global Left Ventricular Assist Device: by Flow USD Million (2025-2030)
  • Figure 48. South America Left Ventricular Assist Device Share (%), by Country
  • Figure 49. Asia Pacific Left Ventricular Assist Device Share (%), by Country
  • Figure 50. Europe Left Ventricular Assist Device Share (%), by Country
  • Figure 51. MEA Left Ventricular Assist Device Share (%), by Country
  • Figure 52. North America Left Ventricular Assist Device Share (%), by Country
  • Figure 53. Global Left Ventricular Assist Device: by Type K Units (2025-2030)
  • Figure 54. Global Left Ventricular Assist Device: by Application K Units (2025-2030)
  • Figure 55. Global Left Ventricular Assist Device: by Flow K Units (2025-2030)
  • Figure 56. South America Left Ventricular Assist Device Share (%), by Country
  • Figure 57. Asia Pacific Left Ventricular Assist Device Share (%), by Country
  • Figure 58. Europe Left Ventricular Assist Device Share (%), by Country
  • Figure 59. MEA Left Ventricular Assist Device Share (%), by Country
  • Figure 60. North America Left Ventricular Assist Device Share (%), by Country
  • Figure 61. Global Left Ventricular Assist Device: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Abiomed, Inc. (United States)
  • Asahi Kasei Corporation (Japan)
  • Abbott Laboratories (United States)
  • Berlin Heart GmbH (Germany)
  • Calon Cardio-Technology Ltd. (United Kingdom)
  • CardiacAssist Technologies (United States)
  • Jarvik Heart, Inc. (United States)
  • Medtronic plc. (Ireland)
  • ReliantHeart, Inc. (United States)
  • Terumo Medical Corporation (United States)
Additional players considered in the study are as follows:
Thoratec Corporation (United States) , Evaheart, Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 214 Pages 77 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Left Ventricular Assist Device Market Quantitative research analysis
Global Left Ventricular Assist Device Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abiomed, Inc. (United States), Asahi Kasei Corporation (Japan), Abbott Laboratories (United States), Berlin Heart GmbH (Germany), Calon Cardio-Technology Ltd. (United Kingdom), CardiacAssist Technologies (United States), Jarvik Heart, Inc. (United States), Medtronic plc. (Ireland), ReliantHeart, Inc. (United States) and Terumo Medical Corporation (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Continuous Adoption in Ventricular Assist Device" is seen as one of major influencing trends for Left Ventricular Assist Device Market during projected period 2023-2030.
The Left Ventricular Assist Device market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Left Ventricular Assist Device Market Report?

Have a Query? Click Here

Other Related Reports

Anesthesia Monitoring Devices Comprehensive Study by Type (Advanced Anesthesia Monitors, Basic Anesthesia Monitors, Integrated Anesthesia Workstation, Others), Application (Cardiology,, Neurology, De...
$ 3750
Therapeutic Respiratory Devices Comprehensive Study by Type (Nebulizers, Humidifiers, Oxygen Concentrators, Ventilators, Gas Analyzers, Capnographs), Application (Hospitals, Clinics, Ambulatory Surge...
$ 3750
Acute Care Ventilator Comprehensive Study by Type (Mechanical, Electronic, Pneumatic), Application (Hospitals and Clinics, Home Care, Ambulatory Care Centers, Emergency Medical Service), Ventilator (...
$ 3650
Benchtop Bioreactors Comprehensive Study by Application (Microbial application, Cell Culture), End-users (Biopharmaceutical Companies, CROs, Academic and Research Institutes, Others), Scale (0-50ML, ...
$ 3450
Baby Warming Devices Comprehensive Study by Type (Portables, Stand-alone, Convertible), Application (Hospitals, Mobile Medical Units, House, Others), Products (Phototherapy Units, Radiant Warmers, In...
$ 3450
Bone Punch Comprehensive Study by Type (Detachable Kerrison, Noir Kerrison, Classical Kerrison, Special Kerrison), Application (Neurosurgery, Spine Surgery, Small Joint Surgery, Others), Distribution...
$ 3450